← Open Payments lookup

GUNJAN KUMAR: Open Payments

NPI 1518963412 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$475 in 23 payments from 12 companies in 2025. Trend: 2023 $46 · 2024 $0 · 2025 $475

Food & beverage: $475
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$135
ABBVIE INC.6$94
Takeda Pharmaceuticals U.S.A., Inc.2$36
Aimmune Therapeutics, Inc.2$33
Janssen Biotech, Inc.2$32
VIVUS LLC2$31
Novo Nordisk Inc2$29
Ferring Pharmaceuticals Inc.1$23
Ipsen Biopharmaceuticals, Inc1$18
Lilly USA, LLC1$17

Products named: XIFAXAN, RINVOQ, ENTYVIO, ZENPEP, TREMFYA, Wegovy, CLENPIQ, SKYRIZI.

Industry payments across NJ — which companies pay providers there.